Search

Your search keyword '"Pagadala, Meghana"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Pagadala, Meghana" Remove constraint Author: "Pagadala, Meghana"
84 results on '"Pagadala, Meghana"'

Search Results

52. Abstract 3825: Germline modifiers of the tumor immune microenvironment reveal drivers of immunotherapy response

53. EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma

54. Accurate genome-wide germline profiling from decade-old archival tissue DNA reveals the contribution of common variants to precancer disease outcome

55. PRState: Incorporating Genetic Ancestry in Prostate Cancer Risk scores for African American Men

56. Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer in the multi-ancestry Million Veteran Program cohort.

57. Discovery of Novel Trans-Ancestry and Ancestry-Specific Gene Loci for Total Testosterone in a Multi-Ancestral Analysis of Men in the Million Veteran Program

58. The landscape of extrachromosomal circular DNA in medulloblastoma

59. Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program

62. Abstract 828: Common genetic variants influence the composition of the tumor immune microenvironment and host anti-tumor responses

63. SnpReportR: A Tool for Clinical Reporting of RNAseq Expression and Variants

64. Additional file 4 of Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes

65. Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response.

66. SnpReportR: A Tool for Clinical Reporting of RNAseq Expression and Variants

67. Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response

68. EPEN-04. ONCOGENIC 3D TUMOR GENOME ORGANIZATION IDENTIFIES NEW THERAPEUTIC TARGETS IN EPENDYMOMA

69. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma

70. Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response

71. Author response: Domain-swapped T cell receptors improve the safety of TCR gene therapy

73. Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response

74. Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response

75. Integrated Germline and Somatic Features Reveal Divergent Immune Pathways Driving Response to Immune Checkpoint Blockade.

76. Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry.

77. Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.

78. Integrated germline and somatic features reveal divergent immune pathways driving ICB response.

79. The GPCR-Gα s -PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure.

80. Prevalence, Morbidity, and Mortality of 1,609 Men with Sex Chromosome Aneuploidy: Results from the Diverse Million Veteran Program Cohort.

81. Epigenetic Germline Variants Predict Cancer Prognosis and Risk and Distribute Uniquely in Topologically Associating Domains.

82. Agent Orange exposure and prostate cancer risk in the Million Veteran Program.

83. Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS.

Catalog

Books, media, physical & digital resources